Table 2

Cost and health impacts of different policy options 2017–2050

Accumulated costs and impacts until
20182020203020402050
Total infections averted
 Status quo203689514810 01913 690
 Screening from 604341259647511 51615 231
 Screening from 407071936819713 56117 374
 Screening from 207842129868514 14617 992
Total hepatitis C-related deaths averted
 Status quo2184119431684913
 Screening from 6033128145635365310
 Screening from 4038144161638885798
 Screening from 2038144162339085835
Total costs (US$ millions)
 Status quo20237395412521386
 Screening from 60451603114114271558
 Screening from 40795926140916701789
 Screening from 209651091155818151931
Average cost per infection averted (US$)
 Status quo998 170540 669185 297124 948101 208
 Screening from 601 039 029478 851176 287123 948102 276
 Screening from 401 124 565478 359171 848123 177102 971
 Screening from 201 230 596512 246179 437128 302107 320
Average cost per deaths averted (US$)
 Status quo9 867 4354 456 291799 119395 182282 029
 Screening from 6013 498 6594 720 165783 710403 650293 380
 Screening from 4021 007 3616 420 448871 637429 658308 537
 Screening from 2025 439 6087 536 489960 442464 426330 929
Incremental cost-effectiveness ratio (ICER)
Incremental infection averted
 Status quo203689514810 01913 690
 Screening from 60231570132614971541
 Screening from 40273677172320462143
 Screening from 2078193488585618
Incremental deaths averted
 Status quo2184119431684913
 Screening from 601344263368397
 Screening from 40416160352489
 Screening from 200062036
Incremental costs (US$ millions)
 Status quo20237395412521386
 Screening from 60248230187176172
 Screening from 40344323267243231
 Screening from 20170164150144142
Incremental cost-effectiveness ratio (infection averted)
 Status quo998 170540 669185 297124 948101 208
 Screening from 601 074 867404 093141 311117 260111 770
 Screening from 401 260 665477 442155 163118 834107 909
 Screening from 202 197 194852 683306 943247 192229 604
Incremental cost-effectiveness ratio (deaths averted)
 Status quo9 867 4354 456 291799 119395 182282 029
 Screening from 6019 277 0535 220 339713 661476 444433 832
 Screening from 4077 654 43919 588 8481 673 009691 156473 235
 Screening from 20DominatedDominated23 046 0957 199 0173 903 209
  • Table shows difference between scenarios in the accumulated costs and health impacts from 2017 until year indicated. We used the 2016 year-average exchange rate29 to convert Korean won to US dollars (KRW 1160) and a discount rate of 3%.30